BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16169353)

  • 1. Chronic obstructive pulmonary disease as a predictor of mortality in patients undergoing percutaneous coronary intervention.
    Selvaraj CL; Gurm HS; Gupta R; Ellis SG; Bhatt DL
    Am J Cardiol; 2005 Sep; 96(6):756-9. PubMed ID: 16169353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chronic obstructive pulmonary disease on survival of patients with coronary heart disease having percutaneous coronary intervention.
    Berger JS; Sanborn TA; Sherman W; Brown DL
    Am J Cardiol; 2004 Sep; 94(5):649-51. PubMed ID: 15342301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative and long-term outcome of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass grafting.
    Angouras DC; Anagnostopoulos CE; Chamogeorgakis TP; Rokkas CK; Swistel DG; Connery CP; Toumpoulis IK
    Ann Thorac Surg; 2010 Apr; 89(4):1112-8. PubMed ID: 20338316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of sex on in-hospital outcomes and long-term survival after contemporary percutaneous coronary intervention.
    Berger JS; Sanborn TA; Sherman W; Brown DL
    Am Heart J; 2006 May; 151(5):1026-31. PubMed ID: 16644329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
    Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
    J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery.
    Thielmann M; Neuhäuser M; Knipp S; Kottenberg-Assenmacher E; Marr A; Pizanis N; Hartmann M; Kamler M; Massoudy P; Jakob H
    J Thorac Cardiovasc Surg; 2007 Aug; 134(2):470-6. PubMed ID: 17662792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels.
    Roy P; Raya V; Okabe T; Pinto Slottow TL; Steinberg DH; Smith K; Xue Z; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2008 Jun; 101(11):1544-9. PubMed ID: 18489931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term survival of patients with chronic obstructive pulmonary disease undergoing coronary artery bypass surgery.
    Leavitt BJ; Ross CS; Spence B; Surgenor SD; Olmstead EM; Clough RA; Charlesworth DC; Kramer RS; O'Connor GT;
    Circulation; 2006 Jul; 114(1 Suppl):I430-4. PubMed ID: 16820614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of an elevated neutrophil to lymphocyte ratio in predicting long-term mortality after percutaneous coronary intervention.
    Duffy BK; Gurm HS; Rajagopal V; Gupta R; Ellis SG; Bhatt DL
    Am J Cardiol; 2006 Apr; 97(7):993-6. PubMed ID: 16563903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous coronary intervention for chronic total occlusions: improved survival for patients with successful revascularization compared to a failed procedure.
    Aziz S; Stables RH; Grayson AD; Perry RA; Ramsdale DR
    Catheter Cardiovasc Interv; 2007 Jul; 70(1):15-20. PubMed ID: 17580364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease.
    Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Kim JJ; Choo SJ; Song H; Chung CH; Lee JW; Park SW; Park SJ
    Circulation; 2008 Apr; 117(16):2079-86. PubMed ID: 18413495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction.
    Wakabayashi K; Gonzalez MA; Delhaye C; Ben-Dor I; Maluenda G; Collins SD; Syed AI; Gaglia MA; Torguson R; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2010 Aug; 106(3):305-9. PubMed ID: 20643237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry).
    Feldman DN; Gade CL; Slotwiner AJ; Parikh M; Bergman G; Wong SC; Minutello RM;
    Am J Cardiol; 2006 Nov; 98(10):1334-9. PubMed ID: 17134624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of acute renal failure following percutaneous coronary intervention on long-term mortality.
    Roghi A; Savonitto S; Cavallini C; Arraiz G; Angoli L; Castriota F; Bernardi G; Sansa M; De Servi S; Pitscheider W; Danzi GB; Reimers B; Klugmann S; Zaninotto M; Ardissino D;
    J Cardiovasc Med (Hagerstown); 2008 Apr; 9(4):375-81. PubMed ID: 18334892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.
    Marcucci R; Paniccia R; Antonucci E; Gori AM; Fedi S; Giglioli C; Valente S; Prisco D; Abbate R; Gensini GF
    Am J Cardiol; 2006 Nov; 98(9):1156-9. PubMed ID: 17056317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular disease burden and in-hospital outcomes among patients undergoing percutaneous coronary intervention in New York State.
    Berger JS; Petersen JL; Brown DL
    Circ Cardiovasc Interv; 2009 Aug; 2(4):317-22. PubMed ID: 20031734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of home warfarin use on the treatment and outcomes of patients undergoing percutaneous coronary intervention.
    Aggarwal A; Dai D; Rumsfeld JS; Klein LW; Roe MT
    Am J Cardiol; 2008 May; 101(10):1413-7. PubMed ID: 18471451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in use of same-day percutaneous coronary intervention for patients with ST-elevation myocardial infarction in Florida, 2001-2005.
    Pathak EB; Strom JA
    Am J Cardiol; 2008 Oct; 102(7):802-8. PubMed ID: 18805101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of outcomes of percutaneous coronary intervention on proximal versus non-proximal left anterior descending coronary artery, proximal left circumflex, and proximal right coronary artery: a cross-sectional study.
    Alidoosti M; Salarifar M; Zeinali AM; Kassaian SE; Dehkordi MR
    BMC Cardiovasc Disord; 2007 Mar; 7():7. PubMed ID: 17335586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.